Key Market Indicator:
F&G: 14
25.439,61 NASDAQ · 47.204,00 DOW · 6.799,95 S&P · 4.097,55 Gold · 64,14 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
© PR Newswire
12.10.2025
ISIN: US28176E1082

Edwards Lifesciences Corp.
EW

LISTED

NYSE
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation - EW
News Preview
NEW YORK, Oct. 12, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Edwards Lifesciences Corporation (NYSE: EW)....
Themefolio
Profiler
Peergroup
© Globe Newswire
12.10.2025
ISIN: US75886F1075

Regeneron Pharmaceuticals Inc
REGN

LISTED

NASDAQ
DB-OTO Results in the New England Journal of Medicine Showcase Dramatic and Sustained Improvements in Hearing and Speech Perception in Children with Profound Genetic Hearing Loss
News Preview
Nearly all participants (11 of 12) experienced clinically meaningful hearing improvements, including three who achieved normal hearing; eight with longer follow-up showed stability or continued improvement in their hearing...
Themefolio
Profiler
Peergroup
© PR Newswire
11.10.2025
ISIN: US8292141053

Simulations Plus Inc
SLP

LISTED

NASDAQ
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
News Preview
NEW YORK, Oct. 11, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar

USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
11.10.2025
ISIN: US34965K1079

Fortrea Holdings Inc
FTRE

LISTED

NASDAQ
Fortrea Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE
News Preview
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Fortrea Holdings, Inc. (NasdaqGS: FTRE). In June 2023, Fortrea was spun off into a standalone, publicly traded company by Labcorp Holdings Inc. In connection wit...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
11.10.2025
ISIN: US53216B1044

LifeMD, Inc.
LFMD

LISTED

NASDAQ
LifeMD Deadline: LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
News Preview
NEW YORK, Oct. 11, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) b...
Themefolio
Profiler
Peergroup
© PR Newswire
11.10.2025
ISIN: US60855R1005

Molina Healthcare Inc
MOH

LISTED

NYSE
Molina Healthcare Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Molina Healthcare, Inc. - MOH
News Preview
NEW YORK CITY and NEW ORLEANS, Oct. 10, 2025 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have untilDecember 2, 2025 to file lead plaintiff applications in a securities class action lawsuit against Molina...
Themefolio
Profiler
Peergroup
© PR Newswire
11.10.2025
ISIN: US23282W6057

Cytokinetics Inc
CYTK

LISTED

NASDAQ
Cytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK
News Preview
NEW YORK and NEW ORLEANS, Oct. 10, 2025 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have untilNovember 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against Cytokineti...
Themefolio
Profiler
Peergroup
© PR Newswire
11.10.2025
ISIN: US5165441032

Lantheus Holdings Inc
LNTH

LISTED

NASDAQ
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lantheus To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Lantheus between February 26, 2025 and Aug...
Themefolio
Profiler
Peergroup
© PR Newswire
11.10.2025
ISIN: US67079U3068

Nutex Health Inc
NUTX

LISTED

NASDAQ
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nutex between August 8, 2024 and August 15, 2...
Themefolio
Profiler
Peergroup
© PR Newswire
11.10.2025
ISIN: KY61559X1045

MoonLake Immunotherapeutics
MLTX

LISTED

NASDAQ
MLTX INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson  Encourages Investors Who Suffered Significant Losses In MoonLake To Contact Him Directly To Discuss Their Options...
Themefolio
Profiler
Peergroup
© BusinessWire
11.10.2025
ISIN: US6047491013

Mirum Pharmaceuticals Inc
TKOMF

LISTED

OTC
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on October 10, 2025, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 45,800 shares of common stock and 22,850 restricted stock units (“RSUs”) to eight new employees under Mirum’s 2020 Inducement P...
Themefolio
Profiler
Peergroup
© PR Newswire
11.10.2025
ISIN: US5165441032

Lantheus Holdings Inc
LNTH

LISTED

NASDAQ
LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lantheus Holdings, Inc. (NASD...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
11.10.2025
ISIN: US0021202025

Atyr Pharma, Inc.
ATYR

LISTED

NASDAQ
aTyr Pharma, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ATYR     
News Preview
The DJS Law Group reminds investors of a class action lawsuit against aTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ: ATYR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of ATYR during the clas...
Themefolio
Profiler
Peergroup
© BusinessWire
11.10.2025
ISIN: US00973Y1082

Akero Therapeutics Inc
AKRO

LISTED

NASDAQ
Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO
News Preview
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Akero Therapeutics, Inc. (NasdaqGS: AKRO) to Novo Nordisk A/S. Under the terms of the proposed transaction, shareholders of Akero will receive $54.00 per share in cash, and a non-transferable...
Themefolio
Profiler
Peergroup
© PR Newswire
11.10.2025
ISIN: US8753721047

Tandem Diabetes Care Inc
TNDM

LISTED

NASDAQ
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US0021202025

Atyr Pharma, Inc.
ATYR

LISTED

NASDAQ
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against aTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ: ATYR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investo...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US60855R1005

Molina Healthcare Inc
MOH

LISTED

NYSE
NYSE: MOH: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Class Action Lawsuit Against Molina Healthcare, Inc.
News Preview
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Molina Healthcare, Inc. (“Molina”) (NYSE: MOH) on behalf of those who purchased or otherwise acquired Molina securities between February 5, 2025, and July 23, 2025, inclusive (the “Class Period”). Th...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US89422G1076

Travere Therapeutics Inc
TVTX

LISTED

NASDAQ
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on October 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 228,600 shares of its common stock to 43 new employees, consisting of inducement stock options to purchase an aggregate of 50,000 shares of common stock a...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US0021202025

Atyr Pharma, Inc.
ATYR

LISTED

NASDAQ
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purch...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US60855R1005

Molina Healthcare Inc
MOH

LISTED

NYSE
Molina Healthcare, Inc. (MOH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 10, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE: MOH) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US8051111016

Savara Inc
SVRA

LISTED

NASDAQ
Savara Inc. (SVRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Oct. 10, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Savara Inc. ("Savara" or the "Company") (NASDAQ: SVRA). IF YOU ARE AN INVES...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US4781601046

Johnson & Johnson
JNJ

LISTED

NYSE
Johnson & Johnson recommends shareholders reject “mini-tender” offer by Tutanota
News Preview
Johnson & Johnson (NYSE: JNJ) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LLC, a limited liability company established pursuant to the laws of the Island of Nevis to purchase up to 500,000 shares of Johnson & Johnson common stock at a price of $145.00 per share in cash. Tutanota’s offer price...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US98978V1035

Zoetis Inc
ZTS

LISTED

NYSE
Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
News Preview
Zoetis Inc. today announced that the Committee for Veterinary Medicinal Products (CVMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of marketing authorization for Lenivia® (izenivetmab) for the reduction of pain associated with osteoarthritis (OA) in dogs. Based on the CVMP’s positive opinion, th...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US4448591028

Humana Inc
HUM

LISTED

NYSE
Humana Inc. to Release Third Quarter 2025 Results on November 5, 2025
News Preview
Humana Inc. (NYSE: HUM) will release its financial results for the third quarter 2025 (3Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on November 5, 2025. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and ear...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US30052C1071

Evolus Inc
EOLS

LISTED

NASDAQ
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant in October of non-qualified stock options to purchase an aggregate of 24,931 shares of Evolus and an aggregate of 31,116 restricted stock units (RSUs) of the company’s common stock to 9 newly hired...
Themefolio
Profiler
Peergroup
© Newsfile
10.10.2025
ISIN: CA74141E1043

PreveCeutical Medical Inc.
PREV

LISTED

CSE
PreveCeutical Announces Results from Annual General and Special Meeting and Increase to Size of Non-Brokered Private Placement
News Preview
Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that all resolutions presented at the Company's annual general and special meeting (the "Meeting") held on Friday, October 10, 2025, including the fo...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US77313F1066

Rocket Pharmaceuticals Inc
RCKT

LISTED

NASDAQ
Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that on October 6, 2025, the Compensation Committee of Rocket’s Board of Directors approved the grant of inducement equity incentive awards...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US22663K1079

Crinetics Pharmaceuticals Inc
CRNX

LISTED

NASDAQ
Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
SAN DIEGO, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on October 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 78,975 shares of its common stock and granted an aggregate of 54,475 restricted stock unit...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US0021202025

Atyr Pharma, Inc.
ATYR

LISTED

NASDAQ
Rosen Law Firm Urges aTyr Pharma, Inc. (NASDAQ: ATYR) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of aTyr Pharma, Inc. (NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025, both dates inclusive (the “Class Period”). aTyr is a clinical stage biotechnology company. For more in...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US3596161097

Fulcrum Therapeutics Inc
FULC

LISTED

NASDAQ
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CAMBRIDGE, Mass., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to new employees. Fulcrum gra...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US92337R1014

Vera Therapeutics Inc
VERA

LISTED

NASDAQ
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
BRISBANE, Calif., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on October 6, 2025, the Compensation Committee of the Board of Directors of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase 135,100 shares of Class A common stock and restricted stock u...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US03770N1019

Apogee Therapeutics Inc
APGE

LISTED

NASDAQ
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $345 Million
News Preview
SAN FRANCISCO and BOSTON, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class profiles in the largest inflammatory and immunology (I&I) markets, today announced the closing of its previously announced underwritt...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US8523123052

STAAR Surgical Co
STAA

LISTED

NASDAQ
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale
News Preview
Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAAR’s outstanding common shares, continues to urge its fellow shareholders to vote on its GREEN Proxy...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: IL0006290147

Teva Pharmaceutical Industries Ltd
TEVA

LISTED

TLV
FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder
News Preview
PARSIPPANY, N.J. and TEL AVIV, Israel and PARIS, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Medincell (Euronext: MEDCL), announced today that the U.S. Food and Drug Administration (FDA) has approved UZEDY® (risperidone) as a once-monthly extended-relea...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US00857U1079

agilon health inc
AGL

LISTED

NYSE
AGL Investor News: Rosen Law Firm Encourages agilon health, inc. Investors to Inquire About Securities Class Action Investigation - AGL
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on beha...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: FR0010557264

AB Science SA
AB

LISTED

EURONEXT
AB Science today reports its revenues for the first half of 2025 and provides an update on its activities
News Preview
        PRESS RELEASE...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US67079U3068

Nutex Health Inc
NUTX

LISTED

NASDAQ
Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman
News Preview
SAN FRANCISCO, Oct. 10, 2025 /PRNewswire/ -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financia...
Themefolio
Profiler
Peergroup
© Newsfile
10.10.2025
ISIN: CA92767B1058

Vireo Growth Inc
VREO

LISTED

CSE
CSE Bulletin: MOC Eligibility Update
News Preview
Toronto, Ontario--(Newsfile Corp. - October 10, 2025) - The following CSE-Listed symbol will become MOC Eligible as detailed below. Symbol Company Name Effective Date AAWH.U...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US5165441032

Lantheus Holdings Inc
LNTH

LISTED

NASDAQ
LNTH ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Class Action Lawsuit Against Lantheus Holdings, Inc. (LNTH)
News Preview
RADNOR, Pa., Oct. 10, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH) on behalf of those who purchased or otherwise acquired Lantheus secu...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US53216B1044

LifeMD, Inc.
LFMD

LISTED

NASDAQ
Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman
News Preview
SAN FRANCISCO, Oct. 10, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives provided investors with a misleading picture of its financial health and growth prospects. The suit, filed in in th...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US5165441032

Lantheus Holdings Inc
LNTH

LISTED

NASDAQ
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 10, 2025 in Lantheus Holdings, Inc. Lawsuit - LNTH
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US67079U3068

Nutex Health Inc
NUTX

LISTED

NASDAQ
Nutex Health Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - NUTX
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US81684M1045

Semler Scientific Inc
SMLR

LISTED

NASDAQ
Levi & Korsinsky Notifies Semler Scientific, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SMLR
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Semler Scientific, Inc. ("Semler Scientific, Inc." or the "Company") (NASDAQ: SMLR) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US23282W6057

Cytokinetics Inc
CYTK

LISTED

NASDAQ
Investors who lost money on Cytokinetics, Incorporated(CYTK) should contact Levi & Korsinsky about pending Class Action - CYTK
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US8051111016

Savara Inc
SVRA

LISTED

NASDAQ
Savara Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SVRA
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US53216B1044

LifeMD, Inc.
LFMD

LISTED

NASDAQ
October 25, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against LFMD
News Preview
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. ("LifeMD, Inc." or the "Company") (NASDAQ: LFMD) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US42328V8761

Solana Company
HSDT

LISTED

NASDAQ
Solana Company (NASDAQ:HSDT) Selects BitGo as Custodian for SOL Treasury Holdings
News Preview
Solana Company (NASDAQ:HSDT) (“HSDT” or “the Company”), formerly known as Helius Medical Technologies, Inc., today announced it has selected BitGo, the digital asset infrastructure company, to serve as a custodian for the Company’s holdings of SOL, the native asset of the Solana Network. The partnership supports Solana Company’s digital asset trea...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US9286611077

VolitionRX Ltd
VNRX

LISTED

XASE
VolitionRx Limited Announces Pricing of $6.0 Million Underwritten Public Offering of Common Stock and Common Stock Warrants
News Preview
HENDERSON, Nev., Oct. 10, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today the pricing of an underwritten public offering of 11,550,000 shares of its common stock and warrants to purchase up to 11,550,000 shares of i...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US53216B1044

LifeMD, Inc.
LFMD

LISTED

NASDAQ
INVESTOR ALERT: Berger Montague Advises LifeMD, Inc. (NASDAQ: LFMD) Investors to Inquire About a Securities Fraud Class Action by October 27, 2025
News Preview
PHILADELPHIA, Oct. 10, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Clas...
Themefolio
Profiler
Peergroup
© Newsfile
10.10.2025
ISIN: US1508377066

CEL-SCI Corp
CVM

LISTED

XASE
CEL-SCI Corporation to Present at LD Micro "Main Event" Investor Conference
News Preview
Vienna, Virginia--(Newsfile Corp. - October 10, 2025) - CEL-SCI Corporation (NYSE American: CVM), a clinical stage cancer immunotherapy company, today announced that Geert Kersten, Chief Executive Officer, is scheduled to present at the LD Micro "Main Event" Investor Conference on October 21, 2025 at 9:30 a.m. PST. The Conference is taking place a...
Themefolio
Profiler
Peergroup
© PR Newswire
10.10.2025
ISIN: US4781601046

Johnson & Johnson
JNJ

LISTED

NYSE
Johnson & Johnson to highlight breadth of its major depressive disorder portfolio at 2025 ECNP Congress
News Preview
17 abstracts from across the Company's portfolio and pipeline highlight new clinical and real-world data on major depressive disorder and treatment-resistant depression New post-hoc analysis of CAPLYTA® (lumateperone) Phase 3 data evaluates the impact on sexual...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US98888T1079

ZimVie, Inc.
ZIMV

LISTED

NASDAQ
ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED
News Preview
PALM BEACH GARDENS, Fla., Oct. 10, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (“ZimVie”) (Nasdaq: ZIMV) today announced that at the special meeting of ZimVie stockholders held on October 10, 2025, the ZimVie stockholders voted to approve the acquisition of ZimVie by an affiliate of ARCHIMED (the “Merger”) pursuant to the terms and conditions of the Agr...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US74587B1017

Pulse Biosciences Inc
PLSE

LISTED

NASDAQ
Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting
News Preview
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced late-breaking clinical study results from the nPulse™ Cardiac Surgical System first-in-human feasibility study at the 39th European Association for Card...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US45784P1012

Insulet Corp
PODD

LISTED

NASDAQ
Insulet to Host Investor Day on November 20, 2025
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, will host an Investor Day at the Company’s Acton, Massachusetts headquarters on Thursday, November 20, 2025. The Investor Day will include presentations from the management team highlighting the...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US1101221083

Bristol-Myers Squibb Co
BMY

LISTED

NYSE
Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics
News Preview
Bristol Myers Squibb (NYSE: BMY, “BMS”) and Orbital Therapeutics (“Orbital”) today announced a definitive agreement under which BMS will acquire Orbital, a privately held biotechnology company pioneering a new generation of RNA medicines that reprogram the immune system in vivo, enabling treatments that provide the precision, control, and flexibil...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
ISIN: US1101221083

Bristol-Myers Squibb Co
BMY

LISTED

NYSE
Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection
News Preview
Bristol Myers Squibb (NYSE: BMY) today announced the launch of its COBENFY Connections™ initiative in partnership with culinary expert, TV host and author Gail Simmons.* Launching on World Mental Health Day, the initiative features real stories from people affected by schizophrenia, including Simmons, who shares her perspective through her brother...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: CH0334081137

CRISPR Therapeutics AG
CRSP

LISTED

NASDAQ
CRISPR Therapeutics Presents New Preclinical Data for CTX460™ Demonstrating In Vivo Gene Correction of Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase™ Editing Platform
News Preview
-Preclinical data presented at the European Society of Gene and Cell Therapy (ESGCT) highlight a potential best-in-class profile-...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US01625V1044

Alignment Healthcare Inc
ALHC

LISTED

NASDAQ
Alignment Healthcare Maintains High 2026 Star Ratings from Medicare, 100% of Members Enrolled in Plans Rated 4 Stars or Higher for Second Consecutive Year
News Preview
Medicare Advantage company adds second 5-star HMO contract in Nevada, Texas HMO earns 4.5 stars in first year Medicare Advantage company adds second 5-star HMO contract in Nevada, Texas HMO earns 4.5 stars in first year...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US05479K1060

Elutia Inc
AZYO

LISTED

NASDAQ
Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors
News Preview
Industry leader brings 40 years of executive and board experience across the global medical technology sector...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
ISIN: US15687V1098

Certara Inc
CERT

LISTED

NASDAQ
Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025
News Preview
RADNOR, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2025 after the market close on Thursday, November 6th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET....
Themefolio
Profiler
Peergroup

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2025 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2025 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 10.11.2025, Calendar Week 46, 314th day of the year, 51 days remaining until EoY.